Duke-NUS and TCD partner to simplify T-cell analysis

The initiative aims to improve infectious disease management.

T Cell Diagnostics Pte. Ltd. (TCD) has licensed an intellectual property and its related know-how from Duke-NUS Medical School to develop point-of-care assays that could simplify the T-cell response analysis.

“Duke-NUS scientists are amongst the most entrepreneurial in Asia, and our culture of innovation is supportive of partnering with startups,” Christopher Laing, Vice-Dean for Innovation and Entrepreneurship at Duke-NUS, said.

The company’s test kits, based on the licensed technology, quantify virus-specific T cells by stimulating biological samples with synthetic peptides and measuring the cytokines released in response.

TCD’s kits can be used on various clinical samples—including whole blood, nasal swabs, and bronchoalveolar lavage fluids—and aim to support the diagnosis and monitoring of infections such as hepatitis B (HBV), hepatitis D (HDV), influenza, SARS-CoV-2, and dengue.

By measuring the number and function of antigen-specific T cells, TCD provides critical insights that can guide diagnosis, treatment, and vaccine development.

Follow the link for more news on

partnership

Reaching the people who run Asia's businesses is harder than it used to be.

Inboxes are crowded. Attention is short. The executives you most want to reach — the founders, CFOs, and operators who actually move budgets — are the hardest to find through the usual channels. If you're building a company, a category, or a reputation, you already know this.

We've spent twenty years building the room they read. Singapore Business Review is where senior decision makers in Singapore and across Southeast Asia come for business coverage they can't get elsewhere — in print, online, and in person at the summits and roundtables we host across seven markets.

If you have something these readers should know about — a point of view worth publishing, a product worth their attention, an event worth their time — we'd like to hear what you're trying to do.

Book a meeting

| Or download the media kit (PDF)

240,000 senior readers quarterly in print Top 1,700 Singapore companies reached

7 markets across Southeast Asia